Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Subjects With Autism Spectrum Disorder
Conditions
Interventions
JNJ-42165279
Placebo
Locations
9
United States
Harmonex Neuroscience Research
Dothan, Alabama, United States
Southwest Autism Research and Resource Center
Phoenix, Arizona, United States
NRC Research Institute
Orange, California, United States
New York Presbyterian Hospital
New York, New York, United States
Nathan Kline Institute
Orangeburg, New York, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Start Date
November 7, 2018
Primary Completion Date
October 17, 2022
Completion Date
October 28, 2022
Last Updated
April 23, 2025
NCT06066983
NCT07439276
NCT06158581
NCT04631042
NCT07421830
NCT05066178
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions